Iminosugar-based GCS inhibitors decrease brain GFAP positive cells. by Karen M. Ashe (349018)

Frequency of B cells increase and T cells decrease in MLN at 4 dpi. by Venkatramana D. Krishna (6716300)

KSHV and miR-K2 decrease anoikis of endothelial cells. by Philippe Kieffer-Kwon (454614)

Prioritising public information leads to an overall decrease in cooperation occurring in networks. by Adam Lee Miles (14123916)

Flow cytometry analysis of Annexin V/FITC-PI on SW480 and HCT116 cells treated with negative control, THC, βCD-THC inclusion complex, and camptothecin. by Zhi Xuan Low (19270163)

Inhibition of ATM kinase activity decreases H3K36me3 on the HPV31 genome and alters processing of late viral RNAs. by Dipendra Gautam (3215988)

Freezing test of acclimated and non-acclimated Col-0, <i>gun5</i> and <i>cch</i> plants. by Peter Kindgren (795049)

Disruption of poly-ADP-ribosylation decreases nucleolar CTCF, disrupts nucleolar structure, and increases <i>rDNA</i> expression. by Paola A. Guerrero (357587)

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…Electrodes C3, CP3’ and CP5’ were pooled. <i>Left</i>: TMS-evoked N100 amplitude continuously decreased during the stimuli 1–500. …”

Hsp90 interacts with BMS1 and decreased Hsp90 function compromises 80S ribosome and polysome stability at 16°C. by Eric A. Franzosa (130063)

SEM images of the samples (a) virgin sample (b) 0.4 wt. % <i>f-MWCNTs</i> (c) 0.5 wt. % <i>f—MWCNTs</i>. by Shaban Gul (14309526)

Image_5_A Satellite dsRNA Attenuates the Induction of Helper Virus-Mediated Symptoms in Aspergillus flavus.JPEG by Yinhui Jiang (6520757)

<i>drp2b</i> shows increased ROS and decreased <i>PR1</i> mRNA to living <i>Pto</i> in a T3SS-independent manner. by John M. Smith (676719)

Hypothetical scenario of what is happening at the epithelial lining of the small intestine at the acute phase of <i>V</i>. <i>cholerae</i> infection. by Aziz Bitar (257322)

“…<p><i>V</i>. <i>cholerae</i> is a Gram(-), flagellated bacterium that secretes several soluble factors, e.g. cholera toxin and <i>V</i>. …”

Postnatal decrease in PV+ cortical interneurons in Fgfr1 mutant mice. by Karen Müller Smith (613941)

“…<p>PV and GFP immunostaining in 8 week old <i>Fgfr1^f/f;Gad67-GFP+</i> control (<b>A</b>, n = 5) and <i>Fgfr1^f/f;hGFAP-Cre;Gad67-GFP+</i> mutant mice (<b>B</b>, n = 9). …”

Citrulline as a nutraceutical protects against eCM. by Irene Gramaglia (6439613)